Abstract
The innate immune system is a significant component of the brain’s defense against infection, especially as the blood-brain barrier restricts access of the members of the adaptive immune system, such as T and B cells. The innate immune system includes Toll-like receptors (TLRs) that recognize pathogen-associated molecular patterns. Within the central nervous system, they are expressed on glial cells and their expression can be modulated by pathological states. Although their function is to recognize foreign pathogens and stimulate a protective immune response through the production of cytokines and interferons, there is emerging evidence that activation of these receptors can result in neurodegeneration. In the current study, the authors assessed the expression of TLR-related genes, using a customized Superarray gene chip, and correlated the expression findings with indices of neurodegeneration. We found that, using a stringent threshold for statistical significance to overcome the potential problem of multiple statistical testing, there were significant correlations between the expression of nine TLR-related genes and reduction in dendritic and synaptic staining. Two of these genes, TLR4 and SIGIRR, were validated by quantitative real-time polymerase chain reaction. Additionally, the authors demonstrated in vitro at the protein level that human primary astrocytes exposed to the toxic human immunodeficiency virus (HIV) envelope protein gp120 had a significant increase in TLR4 protein expression. In conclusion, these findings indicate that TLR-related gene expression may contribute to the development of HIV-related neurodegeneration.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
References
Akechi M, Ito M, Uemura K, Takamatsu N, Yamashita S, Uchiyama K, Yoshioka K, Shiba T (2001). Expression of JNK cascade scaffold protein JSAP1 in the mouse nervous system. Neurosci Res 39: 391–400.
Barger SW, Moerman AM, Mao X (2005). Molecular mechanisms of cytokine-induced neuroprotection: NFkappaB and neuroplasticity. Curr Pharm Des 11: 985–998.
Barton GM, Medzhitov R (2003). Toll-like receptor signaling pathways. Science 300: 1524–1525.
Bonny C, Borsello T, Zine A (2005). Targeting the JNK pathway as a therapeutic protective strategy for nervous system diseases. Rev Neurosci 16: 57–67.
Bottcher T, Von Mering M, Ebert S, Meyding-Lamade U, Kuhnt U, Gerber J, Nau R (2003). Differential regulation of Toll-like receptor mRNAs in experimental murine central nervous system infections. Neurosci Lett 344: 17–20.
Bsibsi M, Ravid R, Gveric D, Van Noort JM (2002). Broad expression of Toll-like receptors in the human central nervous system. J Neuropathol Exp Neurol 61: 1013–1021.
Budka H (1991). Neuropathology of human immunodeficiency virus infection. Brain Pathol 1: 163–175.
Equils O, Shapiro A, Madak Z, Liu C, Lu D (2004). Human immunodeficiency virus type 1 protease inhibitors block toll-like receptor 2 (TLR2)- and TLR4-Induced NF-kappaB activation. Antimicrob Agents Chemother 48: 3905–3911.
Everall I, Luthert P, Lantos P (1993). A review of neuronal damage in human immunodeficiency virus infection: its assessment, possible mechanism and relationship to dementia. J Neuropathol Exp Neurol. 52: 561–566.
Everall IP, Heaton RK, Marcotte TD, Ellis RJ, Mccutchan JA, Atkinson JH, Grant I, Mallory M, Masliah E (1999). Cortical synaptic density is reduced in mild to moderate human immunodeficiency virus neurocognitive disorder. HNRC Group. HIV Neurobehavioral Research Center. Brain Pathol 9: 209–217.
Everall I, Salaria S, Roberts E, Corbeil J, Sasik R, Fox H, Grant I, Masliah E; Hnrc GROUP (2005). Methamphetamine stimulates interferon inducible genes in HIV infected brain. J Neuroimmunol 170(1–2): 158–71
Heggelund L, Muller F, Lien E, Yndestad A, Ueland T, Kristiansen KI, Espevik T, Aukrust P, Froland SS (2004). Increased expression of toll-like receptor 2 on monocytes in HIV infection: possible roles in inflammation and viral replication. Clin Infect Dis 39: 264–269.
Iliev AI, Stringaris AK, Nau R, Neumann H (2004). Neuronal injury mediated via stimulation of microglial toll-like receptor-9 (TLR9). FASEB J 18: 412–414.
Jack CS, Arbour N, Manusow J, Montgrain V, Blain M, Mccrea E, Shapiro A, Antel JP (2005). TLR signaling tailors innate immune responses in human microglia and astrocytes. J Immunol 175: 4320–4330.
Jung DY, Lee H, Jung BY, Ock J, Lee MS, Lee WH, Suk K (2005). TLR4, but not TLR2, signals autoregulatory apoptosis of cultured microglia: a critical role of IFN-beta as a decision maker. J Immunol 174: 6467–6476.
Kelkar N, Gupta S, Dickens M, Davis RJ (2000). Interaction of a mitogen-activated protein kinase signaling module with the neuronal protein JIP3. Mol Cell Biol 20: 1030–1043.
Kurt-Jones EA, Chan M, Zhou S, Wang J, Reed G, Bronson R, Arnold MM, Knipe DM, Finberg RW (2004). Herpes simplex virus 1 interaction with Toll-like receptor 2 contributes to lethal encephalitis. Proc Natl Acad Sci U S A 101: 1315–1320.
Lawn SD, Butera ST, Folks TM (2001). Contribution of immune activation to the pathogenesis and transmission of human immunodeficiency virus type 1 infection. Clin Microbiol Rev 14: 753–777, table.
Lehnardt S, Massillon L, Follett P, Jensen FE, Ratan R, Rosenberg PA, Volpe JJ, Vartanian T (2003). Activation of innate immunity in the CNS triggers neurodegeneration through a Toll-like receptor 4-dependent pathway. Proc Natl Acad Sci U S A 100: 8514–8519.
Liu C, Xu Z, Gupta D, Dziarski R (2001). Peptidoglycan recognition proteins: a novel family of four human innate immunity pattern recognition molecules. J Biol Chem 276: 34686–34694.
Masliah E, Roberts ES, Langford D, Everall I, Crews L, Adame A, Rockenstein E, Fox HS (2004). Patterns of gene dysregulation in the frontal cortex of patients with HIV encephalitis. J Neuroimmunol 157: 163–175.
Mckimmie CS, Johnson N, Fooks AR, Fazakerley JK (2005). Viruses selectively upregulate Toll-like receptors in the central nervous system. Biochem Biophys Res Commun 336: 925–933.
O’Neill LA, Fitzgerald KA, Bowie AG (2003). The Toll-IL-1 receptor adaptor family grows to five members. Trends Immunol. 24: 286–290.
Sasik R, Calvo E, Corbeil J (2002). Statistical analysis of high-density oligonucleotide arrays: a multiplicative noise model. Bioinformatics 18: 1633–1640.
Scumpia PO, Kelly KM, Reeves WH, Stevens BR (2005). Double-stranded RNA signals antiviral and inflammatory programs and dysfunctional glutamate transport in TLR3-expressing astrocytes. Glia 52: 153–162.
Sheeter D, Du P, Rought S, Richman D, Corbeil J (2003). Surface CD4 expression modulated by a cellular factor induced by HIV type 1 infection. AIDS Res Hum Retroviruses 19: 117–123.
Steiner H (2004). Peptidoglycan recognition proteins: on and off switches for innate immunity. Immunol Rev 198: 83–96.
Sundstrom JB, Little DM, Villinger F, Ellis JE, Ansari AA (2004). Signaling through Toll-like receptors triggers HIV-1 replication in latently infected mast cells. J Immunol 172: 4391–4401.
Trillo-Pazos G, Everall IP (1997). From human immunodeficiency virus (HIV) infection of the brain to dementia. Genitourin Med 73: 343–347.
Trillo-Pazos G, Kandanearatchi A, Eyeson J, King D, Vyakarnam A, Everall IP (2004). Infection of stationary human brain aggregates with HIV-1 SF162 and IIIB results in transient neuronal damage and neurotoxicity. Neuropathol Appl Neurobiol 30: 136–147.
Zeinstra E, Wilczak N, Streefland C, De Keyser J (2000). Astrocytes in chronic active multiple sclerosis plaques express MHC class II molecules. Neuroreport 11: 89–91.
Zeinstra EM, Wilczak N, Wilschut JC, Glazenburg L, Chesik D, Kroese FG, De Keyser J (2006). 5HT(4) agonists inhibit interferon-gamma-induced MHC class II and B7 costimulatory molecules expression on cultured astrocytes. J Neuroimmunol.
Zhang D, Zhang G, Hayden MS, Greenblatt MB, Bussey C, Flavell RA, Ghosh S (2004). A toll-like receptor that prevents infection by uropathogenic bacteria. Science 303: 1522–1526.
Author information
Authors and Affiliations
Consortia
Corresponding author
Rights and permissions
About this article
Cite this article
Salaria, S., Badkoobehi, H., Rockenstein, E. et al. Toll-like receptor pathway gene expression is associated with human immunodeficiency virus-associated neurodegeneration. Journal of NeuroVirology 13, 496–503 (2007). https://doi.org/10.1080/13550280701558616
Received:
Revised:
Accepted:
Issue Date:
DOI: https://doi.org/10.1080/13550280701558616